Furthermore, it was found in two mouse models of AML driven by the MLL-AF9 leukemic fusion gene that Ezh2 was required for AML progression (Neff et al., 2012) and functioned to inhibit the differentiation program in leukemic stem cells (Tanaka et al., 2012). This evidence concerns the gene KMT2A and acute myeloid leukemia.